Alpharma Inc (730469) SEC Filing 8-K Material Event for the period ending Wednesday, October 29, 2008

Alpharma Inc

CIK: 730469

View differences made from one to another to evaluate Alpharma Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Alpharma Inc.


Assess how Alpharma Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Alpharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 730469
Form Type: 8-K Corporate News
Accession Number: 0000950123-08-013741
Submitted to the SEC: Wed Oct 29 2008 7:23:21 AM EST
Accepted by the SEC: Wed Oct 29 2008
Period: Wednesday, October 29, 2008
Industry: Pharmaceutical Preparations
  1. Earnings Release
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: